Immuneering Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Immuneering

Access the complete profile.

Immuneering Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	245 Main St Fl 2 Cambridge, MA 02142

Note: Revenues for privately held companies are statistical evaluations.


Immuneering's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Immuneering's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Immuneering is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Immuneering Annual Revenue and Growth Rate

Immuneering	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Immuneering's revenues are gauged from an analysis of company filings.

Immuneering's Income Statement (based on Industry Averages)

Immuneering P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Immuneering has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
January 5, 2021	39	60%	$62 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Immuneering is developing and marketing. Immuneering doesn't have any recent trademark applications, indicating Immuneering is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
DEEP CYCLIC INHIBITION chemical preparations and reagents for pharmaceutical, medical, and clinical purposes; pharmaceuticals, pharmaceutical preparations and substances developed with a computer software platform using biology and chemistry analytics; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer and oncological diseases and disorders	05/15/2023
DISEASE CANCELLING chemical preparations and reagents for pharmaceutical, medical, and medical clinical purposes, namely, for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances developed with a computer software platform using biology and chemistry analytics for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders; pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the integumentary, muscular, skeletal, nervous, circulatory, lymphatic, respiratory, endocrine, urinary/excretory, reproductive and digestive systems, oncological diseases and disorders, and ophthalmological diseases and disorders	12/06/2019
IMMUNEERING Providing medical information in the fields of therapy development, therapy selection, and therapy optimization	02/20/2008

See all trademarks and details in the Full Report.

Market Share of Immuneering's Largest Competitors

A competitive analysis shows these companies are in the same general field as Immuneering, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Immuneering. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BROAD INSTITUTE	Cambridge, MA	100
BEIGENE USA	Cambridge, MA	69
ALNYLAM PHARMACEUTICALS	Cambridge, MA	52
SAGE THERAPEUTICS	Cambridge, MA	47
INTELLIA THERAPEUTICS	Cambridge, MA	35
IPSEN BIOPHARMACEUTICALS	Cambridge, MA	34

Other Companies at 245 Main St Fl 2, Cambridge MA

Company	Headquarters	Revenue ($ MM)
ROOT CAPITAL	Cambridge, MA	100
ENDEAVOUR PARTNERS	Cambridge, MA	6
EMOTIONRX	Cambridge, MA	0
WKDSMRT	Cambridge, MA	0
VINCERE BIOSCIENCES	Cambridge, MA	0

Future Competition: Immuneering's Fastest Growing Competitors

These companies are in the same general field as Immuneering and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)